"Even in this time of uncertainty, Mayo Clinic is a place for hope and healing — and we're committed to delivering the care you need. With options for face-to-face, virtual visits or phone appointments in adherence with federal and state executive orders and guidance. Ranked the best hospital overall by U.S. News & World Report, Mayo Clinic treats more than 150,000 people with cancer each year, providing the best possible cancer care. U.S. News & World Report consistently ranks Mayo Clinic among the top hospitals for cancer in the nation. Mayo Clinic cancer experts are trained and experienced in using the latest, most effective cancer treatment techniques, including The Mayo Clinic Proton Beam Therapy Program."

During the past decade, Mayo Clinic Cancer Center conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 168 clinical trials were completed, i.e. on average, 262.5% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 37 clinical trials were completed. i.e. 148% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mayo Clinic Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 181 trials, followed by "Children's Oncology Group" with 76 trials sponsored, "Radiation Therapy Oncology Group" with 64 trials sponsored, "Eastern Cooperative Oncology Group" with 49 trials sponsored and "Mayo Clinic" with 49 trials sponsored. Other sponsors include 186 different institutions and companies that sponsored additional 96 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mayo Clinic Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 468 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "North Central Cancer Treatment Group" with 19 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator and "Eastern Cooperative Oncology Group" with 14 trials as a collaborator. Other collaborators include 103 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic Cancer Center" are "Breast Cancer" (71 trials), "Leukemia" (52 trials), "Lung Cancer" (52 trials), "Lymphoma" (48 trials) and "Brain and Central Nervous System Tumors" (34 trials). Many other conditions were trialed in "Mayo Clinic Cancer Center" in a lesser frequency.

Most popular intervention types in "Mayo Clinic Cancer Center" are "Drug" (465 trials), "Radiation" (153 trials), "Biological" (149 trials), "Procedure" (111 trials) and "Other" (96 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (93 trials), "cyclophosphamide" (54 trials), "placebo" (50 trials), "filgrastim" (49 trials) and "cisplatin" (46 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic Cancer Center" are 500 trials for "All" genders, 67 trials for "Female" genders and 27 trials for "Male" genders.

Currently, there are NaN active trials in "Mayo Clinic Cancer Center". undefined are not yet recruiting, 27 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 497 completed trials in Mayo Clinic Cancer Center, undefined suspended trials, and 42 terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic Cancer Center, 85 "Phase 1" clinical trials were conducted, 301 "Phase 2" clinical trials and 189 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 27 trials that are defined as “Not Applicable".